An investigation on behalf of former and current employees of Allscripts-Misys Healthcare Solutions (Public, NASDAQ:MDRX) concerning potential Employee Retirement Income Security Act (ERISA) Breach of Fiduciary Duty was announced.

Allscripts-Misys Healthcare Solutions has been accused of securities fraud and according to a an investigation by a law firm under ERISA employees (former and current) of Allscripts-Misys Healthcare Solutions (Public, NASDAQ:MDRX) may be eligible to file a ERISA complaint for putting stock options at risk if they can prove their employer violated its fiduciary duty to them. The Fiduciary duty refers to a companys responsibility to the people who invest in it and if an employer puts the companys interest ahead of the investors, it has broken its fiduciary duty, so the investigation.

Allscripts-Misys Healthcare Solutions faces a securities class action lawsuit over alleged violations of Federal Securities Laws on behalf of purchasers of Allscripts-Misys Healthcare Solutions, Inc. (formerly known as Allscripts Healthcare Solutions, Inc.) (NYSE: MDRX) common stock during the period from May 8, 2007 to February 13, 2008. An investor in Allscripts-Misys Healthcare Solutions (Public, NASDAQ:MDRX) has filed a proposed securities class action lawsuit the United States District Court for the Northern District of Illinois against Allscripts-Misys Healthcare Solutions and others alleging violations of Federal Securities Laws. According to the complaint the plaintiff alleges that Allscripts-Misys Healthcare Solutions and certain of its officers and directors violated the Securities Exchange Act of 1934 by issuing between May 8, 2007 and February 13, 2008 materially false and misleading statements regarding Allscripts-Misys Healthcare Solutionss business prospects. According to the complaint, during May 2007, Allscripts-Misys Healthcare Solutions went 'live with the newest version of its EHR clinical software, Touchworks, version 11 ('V-11).

Among other thing the complaint further alleges that Allscripts-Misys Healthcare Solutions lacked the necessary resources to install V-11 software at customer sites, that Allscripts-Misys Healthcare Solutions had no historical basis to estimate the completion of V-11 or the impact V-11 sales might have on its 2007 revenues and earnings, and that Allscripts-Misys Healthcare Solutions was currently experiencing adverse and continuing delays in the installation of V-11 software systems. Then on February 13, 2008, Allscripts-Misys Healthcare Solutions released its actual 2007 financial results, reporting 2007 revenue of $281.9 million or $18 million below its $300 million guidance confirmed in August 2007 and $5 million short of their November earnings guidance revision. During a conference call with investors that same day, so the complaint, Allscripts-Misys Healthcare Solutions finally admitted to V-11 installation delays that were likely to negatively impact sales and earnings well into 2008. The plaintiff alleges that in response to those announcements, the price of Allscripts-Misys Healthcare Solutions common shares (NYSE: MDRX) fell $4.12 per share, closing at $11.27 on February 14, 2008.

Allscripts-Misys Healthcare Solutions, Inc., located in Chicago, IL, is a provider of clinical software, services, information and connectivity solutions used by the physicians and other health care providers. Allscripts-Misys Healthcare Solutions reported in 2007 Total Revenue of $383.77million with a Net Income of $25.40million and in 2008 Total Revenue of $548.40million with a Net Income of $26.00million. Shares of Allscripts-Misys Healthcare Solutions (Public, NASDAQ:MDRX) traded at $1742 per share recently and were down from over $30 per share in 2007.